These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 7682752)

  • 21. Clinical applications of recombinant human colony-stimulating factors.
    Klingemann HG
    CMAJ; 1989 Jan; 140(2):137-42. PubMed ID: 2642725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical studies of granulocyte colony stimulating factor (G-CSF).
    Scarffe JH; Kamthan A
    Cancer Surv; 1990; 9(1):115-30. PubMed ID: 1703454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colony-stimulating factors.
    Gordon MS; Gabrilove JL
    Curr Opin Oncol; 1990 Dec; 2(6):1152-8. PubMed ID: 1712236
    [No Abstract]   [Full Text] [Related]  

  • 24. The clinical use of colony stimulating factors.
    Moore MA
    Annu Rev Immunol; 1991; 9():159-91. PubMed ID: 1910675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Granulocyte-macrophage colony-stimulating factor.
    Devereux S; Linch DC
    Biotherapy; 1990; 2(4):305-13. PubMed ID: 2148492
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor.
    Hellmich B; Schnabel A; Gross WL
    Semin Arthritis Rheum; 1999 Oct; 29(2):82-99. PubMed ID: 10553980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
    Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO
    Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biological properties and clinical application of filgrastim (G-CSF)].
    Robak T; Krykowski E
    Acta Haematol Pol; 1993; 24(3):239-51. PubMed ID: 7504384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human granulocyte colony-stimulating factor (G-CSF), the premier granulopoietin: biology, clinical utility, and receptor structure and function.
    Tkatch LS; Tweardy DJ
    Lymphokine Cytokine Res; 1993 Dec; 12(6):477-88. PubMed ID: 7510132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colony-stimulating factors: clinical evidence for treatment and prophylaxis of chemotherapy-induced febrile neutropenia.
    Gómez Raposo C; Pinto Marín A; González Barón M
    Clin Transl Oncol; 2006 Oct; 8(10):729-34. PubMed ID: 17074671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulocyte colony-stimulating factor (G-CSF) production and G-CSF receptor structure in patients with congenital neutropenia.
    Guba SC; Sartor CA; Hutchinson R; Boxer LA; Emerson SG
    Blood; 1994 Mar; 83(6):1486-92. PubMed ID: 7510142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloid colony-stimulating factors: use in the newborn.
    Sreenan C; Osiovich H
    Arch Pediatr Adolesc Med; 1999 Sep; 153(9):984-8. PubMed ID: 10482217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative review of colony-stimulating factors.
    Nemunaitis J
    Drugs; 1997 Nov; 54(5):709-29. PubMed ID: 9360058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of GM-CSF in AIDS.
    Scadden DT
    Infection; 1992; 20 Suppl 2():S103-6. PubMed ID: 1283604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G-CSF and GM-CSF in Neutropenia.
    Mehta HM; Malandra M; Corey SJ
    J Immunol; 2015 Aug; 195(4):1341-9. PubMed ID: 26254266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.
    Wu HH; Talpaz M; Champlin RE; Pilat SR; Kurzrock R
    Cancer; 2003 Dec; 98(11):2410-9. PubMed ID: 14635076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biology and clinical applications of GM-CSF].
    Robak T
    Acta Haematol Pol; 1994; 25(2):99-109. PubMed ID: 8067193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF): receptor biology, signal transduction, and neutrophil activation.
    Rapoport AP; Abboud CN; DiPersio JF
    Blood Rev; 1992 Mar; 6(1):43-57. PubMed ID: 1375123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemopoietic growth factors: a review.
    Rowe JM; Rapoport AP
    J Clin Pharmacol; 1992 Jun; 32(6):486-501. PubMed ID: 1378857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant.
    Goa KL; Bryson HM
    Pharmacoeconomics; 1994 Jan; 5(1):56-77. PubMed ID: 10146867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.